Small intestinal bacterial overgrowth in irritable bowel syndrome: frequency and its association with socio-demographic and clinical factors

Mohammad Jane Alam; A. S. M. Salimullah; Iqbal Hossain; Raj Dutta; Sadia Sultana Kamolika

doi:10.18203/2320-6012.ijrms20251287

Authors

Mohammad Jane Alam Department of Gastroenterology, National Gastroliver Institute and Hospital, Mohakhali, Dhaka, Bangladesh
A. S. M. Salimullah Department of Gastroenterology, Dhaka Medical College, Dhaka, Bangladesh
Iqbal Hossain Department of Gastroenterology, National Gastroliver Institute and Hospital, Mohakhali, Dhaka, Bangladesh
Raj Dutta Department of Gastroenterology, National Gastroliver Institute and Hospital, Mohakhali, Dhaka, Bangladesh
Sadia Sultana Kamolika Department of Community Medicine, Shaheed Suhrawardy Medical College, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20251287

Keywords:

Association, Frequency, Irritable bowel syndrome, SIBO, Socio-demographic factors

Abstract

Background: Irritable bowel syndrome (IBS) is a chronic functional relapsing GIT disorder characterized by abdominal pain in association with altered stool form or stool frequency in the absence of any other disease. Small intestinal bacterial overgrowth (SIBO) has been increasingly linked to IBS, particularly its diarrhea-predominant subtype (IBS-D). This study aimed to determine the frequency of SIBO in IBS patients and explore its association with socio-demographic and clinical factors.

Methods: This observational cross-sectional study was conducted in the department of gastroenterology, Dhaka Medical College Hospital (DMCH), Dhaka, Bangladesh from September 2018 to August 2019. In this study, we included a total of 104 IBS patients who attended the gastroenterology department of DMCH.

Results: The mean age of patients was 31.69±10.01 years, with 75% being male. Among all patients, the majority (45%) of them were service holders, and most of them (58.6%) lived in urban areas. Among IBS subtypes, 57% had IBS-D, and 42% had IBS-M. SIBO was detected in 36.5% (38 patients), with a significantly higher prevalence in IBS-D patients (53.3%) compared to IBS-M patients (13.7%) (p<0.001). No significant associations were found between SIBO status and demographic factors such as age, gender, marital status, occupation, or smoking.

Conclusions: The study findings show that SIBO is more prevalent in IBS-D patients than in IBS-M, suggesting a potential role of bacterial overgrowth in the pathophysiology of IBS-D. The frequency of SIBO among IBS-D and IBS-M was 36.5% and IBS-D was the only factor associated with SIBO.

Metrics

Metrics Loading ...

References

Andrews EB, Eaton SC, Hollis KA, Hopkins JS, Ameen V, Hamm LR, et al. Prevalence and demographics of irritable bowel syndrome: results from a large web‐based survey. Aliment Pharmacol Ther. 2005;22(10):935-42. DOI: https://doi.org/10.1111/j.1365-2036.2005.02671.x

Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2017;15(1):35. DOI: https://doi.org/10.1186/s12955-017-0611-2

Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949-58. DOI: https://doi.org/10.1001/jama.2015.0954

Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712-21. DOI: https://doi.org/10.1016/j.cgh.2012.02.029

Perveen I, Hasan M, Masud MA, Bhuiyan MM, Rahman MM. Irritable bowel syndrome in a Bangladeshi urban community: prevalence and health care seeking pattern. Saudi J Gastroenterol. 2009;15(4):239. DOI: https://doi.org/10.4103/1319-3767.56099

Masud MA, Hasan M, Khan AA. Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior. Am J Gastroenterol. 2001;96(5):1547. DOI: https://doi.org/10.1111/j.1572-0241.2001.03760.x

Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000;95(12):3503. DOI: https://doi.org/10.1111/j.1572-0241.2000.03368.x

Wilder‐Smith CH, Materna A, Wermelinger C, Schuler J. Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2013;37(11):1074-83. DOI: https://doi.org/10.1111/apt.12306

Nayak AK, Karnad DR, Abraham P, Mistry FP. Metronidazole relieves symptoms in irritable bowel syndrome: the confusion with so-called ‘chronic amebiasis’. Indian J Gastroenterol. 1997;16:137-9.

Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology. 1984;86(1):174-93. DOI: https://doi.org/10.1016/0016-5085(84)90606-1

King CE, Toskes PP. Small intestine bacterial overgrowth. Gastroenterology. 1979;76(5):1035-55. DOI: https://doi.org/10.1016/S0016-5085(79)91337-4

Ghoshal UC, Srivastava D, Ghoshal U, Misra A. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Eur J Gastroenterol Hepatol. 2014;26(7):753-60. DOI: https://doi.org/10.1097/MEG.0000000000000122

Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy. 2005;51(1):1-22. DOI: https://doi.org/10.1159/000081988

Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, et al. Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol. 2010;25(7):1189-205. DOI: https://doi.org/10.1111/j.1440-1746.2010.06353.x

McCallum R, Schultz C, Sostarich S. Evaluating the role of small intestinal bacterial overgrowth (SIBO) in diarrhea predominant irritable bowel syndrome (IBS-D) patients utilizing the glucose breath test (GBT). Gastroenterology. 2005;128(4 Suppl 2):A460.

Ghoshal UC, Shukla R, Ghoshal U. Small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy. Gut Liver. 2017;11(2):196-208. DOI: https://doi.org/10.5009/gnl16126

Lupascu A, Gabrielli M, Lauritano EC, Scarpellini E, Santoliquido A, Cammarota G, et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther. 2005;22(11-12):1157-60. DOI: https://doi.org/10.1111/j.1365-2036.2005.02690.x

Ghoshal UC, Srivastava D. Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype. World J Gastroenterol. 2014;20(10):2482. DOI: https://doi.org/10.3748/wjg.v20.i10.2482

Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci. 2012;57(5):1321-9. DOI: https://doi.org/10.1007/s10620-012-2033-7

Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150(6):1262-79. DOI: https://doi.org/10.1053/j.gastro.2016.02.032

Sachdeva S, Rawat AK, Reddy RS, Puri AS. Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors. J Gastroenterol Hepatol. 2011;26 Suppl 3:135-8. DOI: https://doi.org/10.1111/j.1440-1746.2011.06654.x

Chu H, Fox M, Zheng X, Deng Y, Long Y, Huang Z, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome: clinical characteristics, psychological factors, and peripheral cytokines. Gastroenterol Res Pract. 2016;2016:3230859. DOI: https://doi.org/10.1155/2016/3230859